An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Gust H. Bardy; Warren M. Smith; Margaret A. Hood; Ian G. Crozier; Iain C. Melton; Luc Jordaens; Dominic Theuns; Robert E. Park; David J. Wright; Derek T. Connelly; Simon P. Fynn; Francis D. Murgatroyd; Johannes Sperzel; Jörg Neuzner; Stefan G. Spitzer; Andrey V. Ardashev; Amo Oduro; Lucas Boersma; Alexander H. Maass; Isabelle C. Van Gelder; Arthur A. Wilde; Pascal F. van Dessel; Reinoud E. Knops; Craig S. Barr; Pierpaolo Lupo; Riccardo Cappato; Andrew A. Grace

Journal ArticleOPEN ACCESS

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Bardy G
Smith W
Hood M
et al.

New England Journal of Medicine (2010) 363(1) 36-44

DOI: 10.1056/nejmoa0909545

685Citations

333Readers

Abstract

Implantable cardioverter-defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, we designed and tested an entirely subcutaneous ICD system.

Cite

CITATION STYLE

APA

Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., … Grace, A. A. (2010). An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. New England Journal of Medicine, 363(1), 36–44. https://doi.org/10.1056/nejmoa0909545

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Abstract

Cite

Register to see more suggestions